2016 annual financial data
ProQR Therapeutics 2016 Operating margin
ProQR Therapeutics 2016 operating margin with verified reported values.
Direct answer
Operating margin was -1,734.14%.
Operating income was -39,573,000 EUR and net income was -39,103,000 EUR.
Operating cash flow was -34,221,000 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,282,000 EUR
- Operating income
- -39,573,000 EUR
- Net income
- -39,103,000 EUR
- Operating cash flow
- -34,221,000 EUR